[(225)Ac]Ac-labeled matuzumab is an effective radioimmunotherapeutic against EGFR-positive triple negative breast cancer.
[(225)Ac]Ac标记的matuzumab是一种有效的放射免疫疗法,可用于治疗EGFR阳性三阴性乳腺癌。
期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-026-02220-z
Tikum Anjong Florence, Fon Dede Api, Njotu Fabrice Ngoh, Henning Nikita, Nwangele Emmanuel, Babeker Hanan, Ketchemen Jessica Pougoue, Doroudi Alireza, Uppalapati Maruti, Fonge Humphrey